[
  {
    "ts": null,
    "headline": "Stocks to Watch Recap: Alphabet, Intel, P&G, Merck",
    "summary": "? After-Hours Earnings: Shares of Google-parent Alphabet and Gilead Sciences rose after earnings releases late Wednesday, while shares of Intel, T-Mobile and Skechers fell. ↘️ IBM (IBM): The tech company warned that macroeconomic uncertainty was prompting businesses to rethink spending.",
    "url": "https://finnhub.io/api/news?id=e7b2fe0db1f9ac3e2c755b7b21717175036d296642b3df98dc43d7bf863c4dcc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745529894,
      "headline": "Stocks to Watch Recap: Alphabet, Intel, P&G, Merck",
      "id": 134067353,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "? After-Hours Earnings: Shares of Google-parent Alphabet and Gilead Sciences rose after earnings releases late Wednesday, while shares of Intel, T-Mobile and Skechers fell. ↘️ IBM (IBM): The tech company warned that macroeconomic uncertainty was prompting businesses to rethink spending.",
      "url": "https://finnhub.io/api/news?id=e7b2fe0db1f9ac3e2c755b7b21717175036d296642b3df98dc43d7bf863c4dcc"
    }
  },
  {
    "ts": null,
    "headline": "Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan",
    "summary": "Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, Gardasil.",
    "url": "https://finnhub.io/api/news?id=c81b51af016080a69384023b8ebb84a1b42fa1b3ed250a88a8e04225c0f57672",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745525298,
      "headline": "Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan",
      "id": 134067514,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, Gardasil.",
      "url": "https://finnhub.io/api/news?id=c81b51af016080a69384023b8ebb84a1b42fa1b3ed250a88a8e04225c0f57672"
    }
  },
  {
    "ts": null,
    "headline": "Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut",
    "summary": "MRK posts better-than-expected first-quarter results but trims its 2025 EPS outlook due to anticipated one-time charges.",
    "url": "https://finnhub.io/api/news?id=2926f56105fdf0f3e6a4c90d1c9f0d469189fd2654cbca7f5dc33ff9104953c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745518800,
      "headline": "Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut",
      "id": 134067515,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MRK posts better-than-expected first-quarter results but trims its 2025 EPS outlook due to anticipated one-time charges.",
      "url": "https://finnhub.io/api/news?id=2926f56105fdf0f3e6a4c90d1c9f0d469189fd2654cbca7f5dc33ff9104953c8"
    }
  },
  {
    "ts": null,
    "headline": "Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1",
    "summary": "Merck (NYSE:MRK) experienced a 2.98% share price increase over the past week, during which several key developments occurred. The company reaffirmed its 2025 financial guidance, despite a slight decline in Q1 sales and ongoing patent litigation with Halozyme Therapeutics. Meanwhile, broader market movements, boosted by a tech-driven rally and anticipation of tariff news, provided a favorable backdrop. The market, seeing an overall 2.3% increase, suggested positive sentiment, possibly...",
    "url": "https://finnhub.io/api/news?id=06dc7fd83e91e546e3a25cdb93ecca63ac93b720afd6eb7a02dc1fe6b47d0751",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745518064,
      "headline": "Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1",
      "id": 134067516,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (NYSE:MRK) experienced a 2.98% share price increase over the past week, during which several key developments occurred. The company reaffirmed its 2025 financial guidance, despite a slight decline in Q1 sales and ongoing patent litigation with Halozyme Therapeutics. Meanwhile, broader market movements, boosted by a tech-driven rally and anticipation of tariff news, provided a favorable backdrop. The market, seeing an overall 2.3% increase, suggested positive sentiment, possibly...",
      "url": "https://finnhub.io/api/news?id=06dc7fd83e91e546e3a25cdb93ecca63ac93b720afd6eb7a02dc1fe6b47d0751"
    }
  },
  {
    "ts": null,
    "headline": "Merck warns of big tariff hit, Hasbro soars, Comcast sinks",
    "summary": "Julie Hyman provides an overview of the top stories of the trading day in just 60 seconds on Yahoo Finance's Market Minute. Merck & Company (MRK) warns investors that it expects a $200 million hit from tariffs. Hasbro (HAS) stock is soaring after reporting a first quarter earnings beat. Comcast (CMCSA) stock sinks after reporting a larger-than-expected loss in broadband customers. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=d890091160714aae270799b6e8fcd73dda377a62a11536c8d480b63c543e5f13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745515253,
      "headline": "Merck warns of big tariff hit, Hasbro soars, Comcast sinks",
      "id": 134067517,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Julie Hyman provides an overview of the top stories of the trading day in just 60 seconds on Yahoo Finance's Market Minute. Merck & Company (MRK) warns investors that it expects a $200 million hit from tariffs. Hasbro (HAS) stock is soaring after reporting a first quarter earnings beat. Comcast (CMCSA) stock sinks after reporting a larger-than-expected loss in broadband customers. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=d890091160714aae270799b6e8fcd73dda377a62a11536c8d480b63c543e5f13"
    }
  },
  {
    "ts": null,
    "headline": "Merck Cuts 2025 Outlook on Tariffs, Charges",
    "summary": "Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.",
    "url": "https://finnhub.io/api/news?id=6062f0764c5dba4386b0c9c68c4def42ee49ad53b7e2b46478c813c340f7b13f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745510700,
      "headline": "Merck Cuts 2025 Outlook on Tariffs, Charges",
      "id": 134067518,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.",
      "url": "https://finnhub.io/api/news?id=6062f0764c5dba4386b0c9c68c4def42ee49ad53b7e2b46478c813c340f7b13f"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. 2025 Q1 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Merck &amp; Co., Inc.",
    "url": "https://finnhub.io/api/news?id=c82708f902f27404a49c83a5f45f9e093601137268261a9bd971dc20505707cc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745503382,
      "headline": "Merck & Co., Inc. 2025 Q1 - Results - Earnings Call Presentation",
      "id": 134063531,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Merck &amp; Co., Inc.",
      "url": "https://finnhub.io/api/news?id=c82708f902f27404a49c83a5f45f9e093601137268261a9bd971dc20505707cc"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Q1 2025 Earnings Call Transcript",
    "summary": "Merck &amp; Co., Inc. (NYSE:MRK) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ETCorporate ParticipantsPeter Dannenbaum - Senior Vice President,...",
    "url": "https://finnhub.io/api/news?id=84c9686d0ce03a3ffb3b554110a7b1234d9c3ad501cbd3fa3ee87ee6256b2e79",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745503285,
      "headline": "Merck & Co., Inc. (MRK) Q1 2025 Earnings Call Transcript",
      "id": 134063533,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck &amp; Co., Inc. (NYSE:MRK) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ETCorporate ParticipantsPeter Dannenbaum - Senior Vice President,...",
      "url": "https://finnhub.io/api/news?id=84c9686d0ce03a3ffb3b554110a7b1234d9c3ad501cbd3fa3ee87ee6256b2e79"
    }
  },
  {
    "ts": null,
    "headline": "Merck, Nokia, Texas Instruments: Trending Tickers",
    "summary": "Brad Smith and Madison Mills take a closer look at some of today's trending tickers ahead of the opening bell on Wall Street. Merck (MRK) lowers its 2025 profit outlook as the drugmaker expects a $200 million tariff hit. Nokia (NOK) warns of an earnings hit from tariffs in the second quarter after the company's first quarter earnings fell short of Wall Street's expectations. Texas Instruments (TXN) issues a strong outlook alongside its earnings beat as demand rebounds. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=de519c3d778d22bd5ebe4d7a2c0c10d96d7709ea662d3f49243366fdbf3643b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745501854,
      "headline": "Merck, Nokia, Texas Instruments: Trending Tickers",
      "id": 134062174,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Brad Smith and Madison Mills take a closer look at some of today's trending tickers ahead of the opening bell on Wall Street. Merck (MRK) lowers its 2025 profit outlook as the drugmaker expects a $200 million tariff hit. Nokia (NOK) warns of an earnings hit from tariffs in the second quarter after the company's first quarter earnings fell short of Wall Street's expectations. Texas Instruments (TXN) issues a strong outlook alongside its earnings beat as demand rebounds. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=de519c3d778d22bd5ebe4d7a2c0c10d96d7709ea662d3f49243366fdbf3643b6"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Health Care Roundup: Market Talk",
    "url": "https://finnhub.io/api/news?id=a3ee43dcd6b0ff428c5e67493ed442d137a0d2877b0b60e308d2841ec0f53bd0",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745498040,
      "headline": "Health Care Roundup: Market Talk",
      "id": 134072546,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "Health Care Roundup: Market Talk",
      "url": "https://finnhub.io/api/news?id=a3ee43dcd6b0ff428c5e67493ed442d137a0d2877b0b60e308d2841ec0f53bd0"
    }
  },
  {
    "ts": null,
    "headline": "Merck takes $200M tariff hit, trimming its gross profits",
    "summary": "The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.",
    "url": "https://finnhub.io/api/news?id=e43fefdc4af23fecfd0b7e7ac0d39b6b14ba6596476d2999602da86cf67fe7d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745494980,
      "headline": "Merck takes $200M tariff hit, trimming its gross profits",
      "id": 134067521,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.",
      "url": "https://finnhub.io/api/news?id=e43fefdc4af23fecfd0b7e7ac0d39b6b14ba6596476d2999602da86cf67fe7d2"
    }
  },
  {
    "ts": null,
    "headline": "Merck details USD200 million tariff hit as first quarter sales fall",
    "summary": "Merck details USD200 million tariff hit as first quarter sales fall",
    "url": "https://finnhub.io/api/news?id=f3f16a945e416e7e6803901cacf76504e91b74fd6c24797bfe0c4e93191d5626",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745494690,
      "headline": "Merck details USD200 million tariff hit as first quarter sales fall",
      "id": 134058525,
      "image": "",
      "related": "MRK",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f3f16a945e416e7e6803901cacf76504e91b74fd6c24797bfe0c4e93191d5626"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Q1 Earnings Review: A Decidedly Mixed Bag - Rating Downgrade",
    "summary": "Bristol-Myers Squibb Company's Q1 2025 earnings reveal revenue decline but EPS growth. Click to discover BMY challenges, dividend appeal, and pipeline potential.",
    "url": "https://finnhub.io/api/news?id=21d3ed5e4f47878cfe3869b6f7216e5f461492a646607544ecbbf8eb8e9b4dc3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745493749,
      "headline": "Bristol-Myers Q1 Earnings Review: A Decidedly Mixed Bag - Rating Downgrade",
      "id": 134062308,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1689585487/image_1689585487.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb Company's Q1 2025 earnings reveal revenue decline but EPS growth. Click to discover BMY challenges, dividend appeal, and pipeline potential.",
      "url": "https://finnhub.io/api/news?id=21d3ed5e4f47878cfe3869b6f7216e5f461492a646607544ecbbf8eb8e9b4dc3"
    }
  },
  {
    "ts": null,
    "headline": "Merck’s (NYSE:MRK) Q1 Sales Beat Estimates",
    "summary": "Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=1f3e7fb605158bc6ba4f47ccfdd6df9974f439dfe72232407bc8656da838116c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745492847,
      "headline": "Merck’s (NYSE:MRK) Q1 Sales Beat Estimates",
      "id": 134059376,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=1f3e7fb605158bc6ba4f47ccfdd6df9974f439dfe72232407bc8656da838116c"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Q1 Earnings Snapshot",
    "summary": "RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $5.08 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share.",
    "url": "https://finnhub.io/api/news?id=5d31cfe2eab5c45a55dbe76948a10eff8859bd45a9dc1db88b3b8f54710e0611",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745491217,
      "headline": "Merck: Q1 Earnings Snapshot",
      "id": 134059377,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $5.08 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share.",
      "url": "https://finnhub.io/api/news?id=5d31cfe2eab5c45a55dbe76948a10eff8859bd45a9dc1db88b3b8f54710e0611"
    }
  },
  {
    "ts": null,
    "headline": "Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?",
    "summary": "Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, Gardasil.",
    "url": "https://finnhub.io/api/news?id=e7e1d30a1004a3df355b524c42d47fc8e3d38f626506225f376e8b652c196bd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745490618,
      "headline": "Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?",
      "id": 134059379,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, Gardasil.",
      "url": "https://finnhub.io/api/news?id=e7e1d30a1004a3df355b524c42d47fc8e3d38f626506225f376e8b652c196bd9"
    }
  },
  {
    "ts": null,
    "headline": "Merck Announces First-Quarter 2025 Financial Results",
    "summary": "RAHWAY, N.J., April 24, 2025--Merck Announces First-Quarter 2025 Financial Results",
    "url": "https://finnhub.io/api/news?id=b84b33f97b20bd4319791e620d17ef3f3334cd07d04ca5ce5764223a2d51c383",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745490600,
      "headline": "Merck Announces First-Quarter 2025 Financial Results",
      "id": 134059380,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., April 24, 2025--Merck Announces First-Quarter 2025 Financial Results",
      "url": "https://finnhub.io/api/news?id=b84b33f97b20bd4319791e620d17ef3f3334cd07d04ca5ce5764223a2d51c383"
    }
  },
  {
    "ts": null,
    "headline": "Merck Earnings Beat Expectations. Investors Are Still Worried.",
    "summary": "Merck Earnings Beat Expectations. Investors Are Still Worried.",
    "url": "https://finnhub.io/api/news?id=50c9af2411498ed9dad25c199dcf4bea5e40e52b48b85b371c867d287b988811",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745488560,
      "headline": "Merck Earnings Beat Expectations. Investors Are Still Worried.",
      "id": 134147652,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck Earnings Beat Expectations. Investors Are Still Worried.",
      "url": "https://finnhub.io/api/news?id=50c9af2411498ed9dad25c199dcf4bea5e40e52b48b85b371c867d287b988811"
    }
  },
  {
    "ts": null,
    "headline": "Merck Slapped With Lawsuit Over Cancer Treatment",
    "summary": "By Katherine Hamilton Halozyme Therapeutics is suing Merck for patent infringement. The San Diego biotechnology company said Thursday it believes a proposed form of Merck's cancer medicine...",
    "url": "https://finnhub.io/api/news?id=ecc333f750e011392aa10661c8d0feb0504ff6f923eaaf7eef1929bb3411795c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745487308,
      "headline": "Merck Slapped With Lawsuit Over Cancer Treatment",
      "id": 134060445,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Katherine Hamilton Halozyme Therapeutics is suing Merck for patent infringement. The San Diego biotechnology company said Thursday it believes a proposed form of Merck's cancer medicine...",
      "url": "https://finnhub.io/api/news?id=ecc333f750e011392aa10661c8d0feb0504ff6f923eaaf7eef1929bb3411795c"
    }
  },
  {
    "ts": null,
    "headline": "Merck absorbs $200 million in tariff costs into its earnings and full-year outlook",
    "summary": "Merck absorbs $200 million in tariff costs into its earnings and full-year outlook",
    "url": "https://finnhub.io/api/news?id=6eca4f1e1b48f8da4336b5da3e5f42bd37102829c295be75b923b355c1174d75",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745486220,
      "headline": "Merck absorbs $200 million in tariff costs into its earnings and full-year outlook",
      "id": 134072570,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck absorbs $200 million in tariff costs into its earnings and full-year outlook",
      "url": "https://finnhub.io/api/news?id=6eca4f1e1b48f8da4336b5da3e5f42bd37102829c295be75b923b355c1174d75"
    }
  },
  {
    "ts": null,
    "headline": "Merck : 1Q25 Merck Earnings Presentation",
    "summary": "First-Quarter 2025 Sales and Earnings Merck & Co., Inc., Rahway, N.J., USA April 24, 2025 ...",
    "url": "https://finnhub.io/api/news?id=8de92f4f53a171d67fe73fedc4c09d6eac52d41dceeec929a844a016fca4c737",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745482210,
      "headline": "Merck : 1Q25 Merck Earnings Presentation",
      "id": 134058785,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "First-Quarter 2025 Sales and Earnings Merck & Co., Inc., Rahway, N.J., USA April 24, 2025 ...",
      "url": "https://finnhub.io/api/news?id=8de92f4f53a171d67fe73fedc4c09d6eac52d41dceeec929a844a016fca4c737"
    }
  },
  {
    "ts": null,
    "headline": "Merck : 1Q25 Merck Other Financial Disclosures",
    "summary": "Merck & Co., Inc. Financial Highlights Package ...",
    "url": "https://finnhub.io/api/news?id=7adc343b2edb1f018b106123087c4b08e74b585566d9f2e6a5c8540a12b24510",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745482209,
      "headline": "Merck : 1Q25 Merck Other Financial Disclosures",
      "id": 134058787,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck & Co., Inc. Financial Highlights Package ...",
      "url": "https://finnhub.io/api/news?id=7adc343b2edb1f018b106123087c4b08e74b585566d9f2e6a5c8540a12b24510"
    }
  },
  {
    "ts": null,
    "headline": "Merck : 1Q25 Merck Earnings Announcement",
    "summary": "1 - News Release ____________________________________________________________________________ Merck Announces First-Quarter 2025...",
    "url": "https://finnhub.io/api/news?id=54dd293ace0bc077755aec5a694c8ca633e9d88a350ff78aceefb06e7cb2d227",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745482209,
      "headline": "Merck : 1Q25 Merck Earnings Announcement",
      "id": 134058786,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "1 - News Release ____________________________________________________________________________ Merck Announces First-Quarter 2025...",
      "url": "https://finnhub.io/api/news?id=54dd293ace0bc077755aec5a694c8ca633e9d88a350ff78aceefb06e7cb2d227"
    }
  },
  {
    "ts": null,
    "headline": "Merck : 1Q25 Prepared Remarks",
    "summary": "Merck & Co., Inc, Rahway, NJ USA First-Quarter 2025 Sales and Earnings Prepared Remarks April 24, 2025 ...",
    "url": "https://finnhub.io/api/news?id=7677706710632ff62279d8e8cb0e987a7933f38d1c61f6c33f99c3b655e0641e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745482208,
      "headline": "Merck : 1Q25 Prepared Remarks",
      "id": 134058788,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck & Co., Inc, Rahway, NJ USA First-Quarter 2025 Sales and Earnings Prepared Remarks April 24, 2025 ...",
      "url": "https://finnhub.io/api/news?id=7677706710632ff62279d8e8cb0e987a7933f38d1c61f6c33f99c3b655e0641e"
    }
  },
  {
    "ts": null,
    "headline": "Merck 1Q Net Up, But 2025 Adjusted EPS View Cut on Tariffs, Charges",
    "summary": "By Rob Curran Merck's first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for...",
    "url": "https://finnhub.io/api/news?id=b53aa053d2c0e57255b735c53b299f380f9b0c8dec04fa4d94b9cc4aa8087af6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745478862,
      "headline": "Merck 1Q Net Up, But 2025 Adjusted EPS View Cut on Tariffs, Charges",
      "id": 134058358,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Rob Curran Merck's first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for...",
      "url": "https://finnhub.io/api/news?id=b53aa053d2c0e57255b735c53b299f380f9b0c8dec04fa4d94b9cc4aa8087af6"
    }
  },
  {
    "ts": null,
    "headline": "Merck 1Q Net Up, But 2025 Adj EPS View Cut on Tariffs, Charges",
    "summary": "Merck 1Q Net Up, But 2025 Adj EPS View Cut on Tariffs, Charges",
    "url": "https://finnhub.io/api/news?id=62a78cb5196aca5ed3a1579529cc7135d3081078d17ca71c452364dc0bdcc60d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745477880,
      "headline": "Merck 1Q Net Up, But 2025 Adj EPS View Cut on Tariffs, Charges",
      "id": 134072571,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck 1Q Net Up, But 2025 Adj EPS View Cut on Tariffs, Charges",
      "url": "https://finnhub.io/api/news?id=62a78cb5196aca5ed3a1579529cc7135d3081078d17ca71c452364dc0bdcc60d"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet results headline another big batch of corporate earnings",
    "summary": "Alphabet results headline another big batch of corporate earnings",
    "url": "https://finnhub.io/api/news?id=3dae222222cf785bb5e18fa54ddb76073f082ed6c3e0a57dac93cbdeedda26a1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745474098,
      "headline": "Alphabet results headline another big batch of corporate earnings",
      "id": 134072572,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Alphabet results headline another big batch of corporate earnings",
      "url": "https://finnhub.io/api/news?id=3dae222222cf785bb5e18fa54ddb76073f082ed6c3e0a57dac93cbdeedda26a1"
    }
  }
]